Liang Shu

2.7k total citations
90 papers, 2.1k citations indexed

About

Liang Shu is a scholar working on Psychiatry and Mental health, Molecular Biology and Pharmacology. According to data from OpenAlex, Liang Shu has authored 90 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Psychiatry and Mental health, 18 papers in Molecular Biology and 17 papers in Pharmacology. Recurrent topics in Liang Shu's work include Schizophrenia research and treatment (18 papers), Treatment of Major Depression (11 papers) and Liver Disease Diagnosis and Treatment (8 papers). Liang Shu is often cited by papers focused on Schizophrenia research and treatment (18 papers), Treatment of Major Depression (11 papers) and Liver Disease Diagnosis and Treatment (8 papers). Liang Shu collaborates with scholars based in China, United States and Australia. Liang Shu's co-authors include Tianmei Si, Qinhe Yang, Yuanjun Deng, Yupei Zhang, Yifang He, Yanning Chen, Kairui Tang, Runsen Chen, Jing Chen and Yinji Liang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Virology and Scientific Reports.

In The Last Decade

Liang Shu

84 papers receiving 2.0k citations

Peers

Countries citing papers authored by Liang Shu

Since Specialization

Citations

This map shows the geographic impact of Liang Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang Shu more than expected).

Fields of papers citing papers by Liang Shu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liang Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang Shu. The network helps show where Liang Shu may publish in the future.

Co-authorship network of co-authors of Liang Shu

This figure shows the co-authorship network connecting the top 25 collaborators of Liang Shu. A scholar is included among the top collaborators of Liang Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liang Shu. Liang Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cuproptosis-related genes are involved in immunodeficiency following ischemic stroke 2024 ·Archives of Medical Science ·(unknown), Cong Yu, Liang Shu, Dabin Ren, Ping Zheng	6
2	Construction a novel osteoporosis model in immune-deficient mice with natural ageing 2024 ·Biochemical and Biophysical Research Communications ·Zhaoxia Ma, (unknown), (unknown), Zhen Wu, Liang Shu, (unknown), (unknown), Min Hu, (unknown)	1
3	Integrated analysis of single cell‐RNA sequencing and Mendelian randomization identifies lactate dehydrogenase B as a target of melatonin in ischemic stroke 2024 ·CNS Neuroscience & Therapeutics ·Fei Shi, Guiyun Zhang, (unknown), Liang Shu, Cong Yu, Dabin Ren, (unknown), Ping Zheng	5
4	Brain Functional Alterations in Patients With Benign Paroxysmal Positional Vertigo Demonstrate the Visual–Vestibular Interaction and Integration 2024 ·Brain and Behavior ·(unknown), Liang Shu, (unknown), Xiaoxia Du, (unknown), Hui Pan, Guo-hong Cui, Jian‐Ren Liu, Wei Chen	0
5	A novel pulmonary fibrosis NOD/SCID murine model with natural aging 2024 ·BMC Pulmonary Medicine ·Zhaoxia Ma, (unknown), (unknown), Zhen Wu, Liang Shu, (unknown), (unknown), Shi‐Jun Yue, Min Hu, (unknown)	2
6	Semaphorin 3D inhibits proliferation and migration of papillary thyroid carcinoma by regulating MAPK/ERK signaling pathway 2022 ·Molecular Biology Reports ·(unknown), (unknown), Fei Wu, (unknown), Qian Yang, Liang Shu, (unknown), Xiangyu Zhou	5
7	4,5-di-O-caffeoylquinic acid methyl ester isolated from Lonicera japonica Thunb. targets the Keap1/Nrf2 pathway to attenuate H2O2-induced liver oxidative damage in HepG2 cells 2020 ·Phytomedicine ·Lingyun Xiao, Liang Shu, Lanlan Ge, Haoqiang Wan, Weigang Wu, Jia Fei, Shipin Wu, Boping Zhou, Xiaobin Zeng	26
8	Mechanisms of transformation of nicotinamide mononucleotides to cerebral infarction hemorrhage based on MCAO model 2019 ·Saudi Journal of Biological Sciences ·Liang Shu, Xiaolei Shen, Yaxue Zhao, Rong Zhao, Xinwei He, (unknown), Jingjing Su, Qiang Li, Jian‐Ren Liu	6
9	Chaihu‐Shugan‐San Decoction Modulates Intestinal Microbe Dysbiosis and Alleviates Chronic Metabolic Inflammation in NAFLD Rats via the NLRP3 Inflammasome Pathway 2018 ·Evidence-based Complementary and Alternative Medicine ·Yinji Liang, Yupei Zhang, Yuanjun Deng, Liang Shu, Yifang He, Yanning Chen, Chan Liu, Chenli Lin, (unknown), (unknown), Qinhe Yang	43
10	Anticholinergic use trends in 14,013 patients with schizophrenia from three national surveys on the use of psychotropic medications in China (2002–2012) 2017 ·Psychiatry Research ·Yun‐Ai Su, (unknown), Qian Li, Yu‐Tao Xiang, Liang Shu, Xin Yu, Yuping Ning, Kerang Zhang, Tao Li, (unknown), Keqing Li, Tianmei Si	7
11	Electroconvulsive Therapy in Schizophrenia in China 2016 ·Journal of Ect ·Qian Li, Yun‐Ai Su, Yu‐Tao Xiang, Liang Shu, Xin Yu, Gábor S. Ungvári, Stephen J. Seiner, Helen Chiu, Yu-Ping Ning, (unknown), (unknown), Tao Li, (unknown), (unknown), (unknown), (unknown), Ke-Qing Li, Tian-Mei Si	8
12	Antipsychotic Medications in Major Depression and the Association with Treatment Satisfaction and Quality of Life 2015 ·Chinese Medical Journal ·Yuxi Wang, Yu‐Tao Xiang, Yun‐Ai Su, Qian Li, Liang Shu, Chee H. Ng, Gábor S. Ungvári, Helen F.K. Chiu, (unknown), Gaohua Wang, (unknown), Tao Li, Lizhong Sun, Jianguo Shi, (unknown), (unknown), Keqing Li, Xin Yu, Tianmei Si	4
13	Long-Term Benzodiazepine Use in Patients With Major Depressive Disorder in China 2013 ·Perspectives In Psychiatric Care ·(unknown), Yu‐Tao Xiang, Yun‐Ai Su, Liang Shu, Xin Yu, Amy M. Kilbourne, Gábor S. Ungvári, Helen Chiu, Cui Ma, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ke-Qing Li, Tian-Mei Si	3
14	Comparable efficacy and safety of 8 weeks treatment with agomelatine 25–50 mg or fluoxetine 20–40 mg in Asian out-patients with major depressive disorder 2013 ·Asian Journal of Psychiatry ·Liang Shu, Ahmad Hatim Sulaiman, Yu‐Shu Huang, (unknown), (unknown), (unknown)	15
15	Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia 2011 ·SHILAP Revista de lepidopterología ·Hongyan Zhang, Huafang Li, Liang Shu, et al., (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
16	Effects of Plant Population Density on Fractal Dimension of Corn Based on Image Processing 2009 ·ACTA AGRONOMICA SINICA ·Liang Shu	1
17	Laboratory Study of Coreopsis Extracts on Reducing Blood Lipid in Hyperlipemia Model Mice 2009 ·Liang Shu	8
18	Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population 2006 ·Depression and Anxiety ·Peixian Mao, Yi‐lang Tang, Feng Jiang, Liang Shu, (unknown), Ming Li, Mincai Qian, Cui Ma, Philip B. Mitchell, Zhuo‐Ji Cai	31
19	The Reliability,Validity of PANSS and its Implication 2004 ·Zhongguo xinli weisheng zazhi ·Liang Shu	57
20	Association study between interleukin-1β gene (IL-1β) and schizophrenia 2003 ·Life Sciences ·Jianzhong Yang, Tianmei Si, (unknown), Yan Ruan, Yonghua Han, Xiling Wang, Mo Zhou, (unknown), (unknown), Hongyan Zhang, Qingmei Kong, Cui Liu, (unknown), Yaqin Yu, (unknown), Liang Shu, Dalong Ma, Jun Wei, Dai Zhang	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact